Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
CDC’s website is being modified to comply with President Trump’s Executive Orders.
Volume 16, Number 7—July 2010
Dispatch

Novel Human Parvovirus 4 Genotype 3 in Infants, Ghana

Marcus Panning1, Robin Kobbe, Silke Vollbach, Ana Maria Bispo de Filippis, Samuel Adjei, Ohene Adjei, Sung Sup Park, Jürgen May, and Anna Maria Eis-HübingerComments to Author 
Author affiliations: Institute of Virology, Bonn, Germany (M. Panning, S. Vollbach, J.F. Drexler, C. Drosten, A.M. Eis-Hübinger); Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany (R. Kobbe, J. May); Ministry of Health/Ghana Health Service, Agona, Ghana (S. Adjei); Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana (O. Adjei)

Main Article

Figure

Phylogenetic analysis of human parvovirus 4 (PARV4) nucleotide sequences. The concatenated dataset of 746 open reading frame (ORF) 1 nt and 558 ORF2 nt (except for strains 14 [550 nt sequenced in ORF1] and 16 [218 nt sequenced in ORF2]) was subjected to neighbor-joining–based phylogenetic analysis with 1,000 bootstrap replicates in MEGA4 by using the Kimura substitution model and the complete deletion option for gaps (14). Bovine hokovirus was used as an outgroup because it is the closest relati

Figure. Phylogenetic analysis of human parvovirus 4 (PARV4) nucleotide sequences. The concatenated dataset of 746 open reading frame (ORF) 1 nt and 558 ORF2 nt (except for strains 14 [550 nt sequenced in ORF1] and 16 [218 nt sequenced in ORF2]) was subjected to neighbor-joining–based phylogenetic analysis with 1,000 bootstrap replicates in MEGA4 by using the Kimura substitution model and the complete deletion option for gaps (14). Bovine hokovirus was used as an outgroup because it is the closest relative to human PARV4. Numbers next to branches indicate bootstrap support values in percent (only selected branches are annotated). Numbers next to strain designations indicate PARV4 genotypes 1, 2, and 3. Sequences are deposited in GenBank (accession nos. GU951546–GU951569); sequencing primers available upon request from the authors. Scale bar indicates nucleotide substitutions per site.

Main Article

References
  1. Jones  MS, Kapoor  A, Lukashov  VV, Simmonds  P, Hecht  F, Delwart  E. New DNA viruses identified in patients with acute viral infection syndrome. J Virol. 2005;79:8230–6. DOIPubMedGoogle Scholar
  2. Fryer  JF, Kapoor  A, Minor  PD, Delwart  E, Baylis  SA. Novel parvovirus and related variant in human plasma. Emerg Infect Dis. 2006;12:151–4.PubMedGoogle Scholar
  3. Fryer  JF, Lucas  SB, Padley  D, Baylis  SA. Parvoviruses PARV4/5 in hepatitis C virus–infected patient. Emerg Infect Dis. 2007;13:175–6. DOIPubMedGoogle Scholar
  4. Manning  A, Willey  SJ, Bell  JE, Simmonds  P. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis. 2007;195:1345–52. DOIPubMedGoogle Scholar
  5. Simmonds  P, Manning  A, Kenneil  R, Carnie  FW, Bell  JE. Parenteral transmission of the novel human parvovirus PARV4. Emerg Infect Dis. 2007;13:1386–8.PubMedGoogle Scholar
  6. Sharp  CP, Lail  A, Donfield  S, Simmons  R, Leen  C, Klenerman  P, High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. J Infect Dis. 2009;200:1119–25. DOIPubMedGoogle Scholar
  7. Norja  P, Hokynar  K, Aaltonen  LM, Chen  R, Ranki  A, Partio  EK, Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A. 2006;103:7450–3. DOIPubMedGoogle Scholar
  8. Parsyan  A, Szmaragd  C, Allain  JP, Candotti  D. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol. 2007;88:428–31. DOIPubMedGoogle Scholar
  9. Simmonds  P, Douglas  J, Bestetti  G, Longhi  E, Antinori  S, Parravicini  C, A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol. 2008;89:2299–302. DOIPubMedGoogle Scholar
  10. Kobbe  R, Kreuzberg  C, Adjei  S, Thompson  B, Langefeld  I, Thompson  PA, A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clin Infect Dis. 2007;45:16–25. DOIPubMedGoogle Scholar
  11. Lassey  AT, Damale  NK, Bekoe  V, Klufio  CA. Hepatitis C virus seroprevalence among mothers delivering at the Korle-Bu Teaching Hospital, Ghana. East Afr Med J. 2004;81:198–201.PubMedGoogle Scholar
  12. Fryer  JF, Delwart  E, Hecht  FM, Bernardin  F, Jones  MS, Shah  N, Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion. 2007;47:1054–61. DOIPubMedGoogle Scholar
  13. Kosakovsky Pond  SL, Posada  D, Gravenor  MB, Woelk  CH, Frost  SD. GARD: a genetic algorithm for recombination detection. Bioinformatics. 2006;22:3096–8. DOIPubMedGoogle Scholar
  14. Tamura  K, Dudley  J, Nei  M, Kumar  S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–9. DOIPubMedGoogle Scholar

Main Article

1Current affiliation: Institute for Medical Microbiology and Hygiene, Freiburg, Germany.

Page created: March 02, 2011
Page updated: March 02, 2011
Page reviewed: March 02, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external